GLP-1 meds reduce heart events in obese adults with autoimmune disease GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease People with both obesity and an autoimmune disease treated with a GLP-1-based medication had fewer ER visits and lower mortality, in a new study in the Journal of the American Heart Association The analysis of more than 26,000 adults in the U.S
Protocols should specify how long reconstituted solutions remain stable, how waste is disposed of, and how data will be recorded to prevent selective reporting
Collectively, these findings provide compelling experimental evidence that circadian disruption promotes chronic inflammation and associated immune system dysregulation 136
Sometimes in as little as one to two weeks, Prozac starts to ease the physical signs of depression including erratic sleep, appetite, or activity levels
This formula thoughtfully includes aglycone isoflavones and equol-generating components to support women's changing rhythms with age
